CareCloud (CCLD)
(Real Time Quote from BATS)
$2.47 USD
+0.11 (4.66%)
Updated Sep 10, 2024 03:50 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
CCLD 2.47 +0.11(4.66%)
Will CCLD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CCLD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CCLD
Fast-paced Momentum Stock CareCloud (CCLD) Is Still Trading at a Bargain
Zacks Industry Outlook Highlights Medical Systems, Clover Health Investments and CareCloud
CCLD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom
Why Fast-paced Mover CareCloud (CCLD) Is a Great Choice for Value Investors
CareCloud, Inc. (CCLD) Q2 Earnings and Revenues Beat Estimates
Other News for CCLD
CareCloud obtained 99% of the minimum required 'FOR' votes
99% of Required Votes Obtained for CareCloud?s Series A Preferred Stock Proposal, Proxy Vote Solicitation Continues
CareCloud (CCLD) Receives a Buy from Benchmark Co.
CareCloud price target raised by 50c at Benchmark, here's why
Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th